Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways

Barbara Wegiel(Beth Israel Deaconess Medical Center), Anders Bjartell(Lund University)

PLoS ONE

November 20, 2009

10.1371/journal.pone.0007953

Cited by 65

Related Papers

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

|European Urology|2016|414

Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth

|Cancer Research|2013|371

Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

|European Journal of Cancer|2023|156

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

|European Urology|2020|132

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

|European Urology|2018|93